IQ-AI Limited Imaging Biometrics Installs IB Nimble(TM) For MCW
July 19 2023 - 1:00AM
RNS Non-Regulatory
TIDMIQAI
IQ-AI Limited
19 July 2023
19 July 2023
IQ-AI Ltd
("IQ-AI" or the "Company")
Imaging Biometrics Installs IB Nimble(TM) For MCW Bone Mets
Treatment
Imaging Biometrics, LLC (IB), a wholly-owned subsidiary of IQ-AI
Ltd (LSE: IQAI, OTCQB: IQAIF), today announced that its handheld
application, IB Nimble, has been adopted by Orthopedic Department
of the Medical College of Wisconsin for use in their treatment of
bone metastases. The handheld app provides real-time collaboration
amongst multi-disciplinary teams securely and asynchronously.
Designed initially by Dr. Joseph Bovi, MD, Professor of
Radiation Oncology and Neurosurgery at MCW, for brain metastases,
IB Nimble's base functionality has been enhanced to accommodate any
disease or pathology that requires multi-disciplinary input. The
clinical benefit of providing optimized treatments faster to
patients with brain metastases is now being afforded to patients
with bone mets.
"This marks the first installation for use in diseases sites
other than brain metastases and demonstrates that IB Nimble is
ready for widespread deployment," said Josh McComack, IB's Director
of Software Engineering.
--ENDS-
The Directors of the Company accept responsibility for the
contents of this announcement.
For further information, please contact:
IQ-AI Ltd
Trevor Brown/Vinod Kaushal/Brett Skelly/Michael Schmainda
Tel: 020 7469 0930
Peterhouse Capital Limited (Financial Adviser and Broker)
Lucy Williams/Heena Karani
Tel: 020 7220 9797
About Imaging Biometrics(R) LLC: IB is a wholly-owned subsidiary
of IQ-AI Limited, (LON: IQAI) (OTCQB: IQAIF), and focuses on
delivering quantitative imaging platforms and therapeutics that
transform how clinicians diagnose and treat patients more
efficiently and effectively. For more information about Imaging
Biometrics, visit the
company's website at www.imagingbiometrics.com . Follow IB on Twitter, @IQAI_IB.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRARPMATMTABBIJ
(END) Dow Jones Newswires
July 19, 2023 02:00 ET (06:00 GMT)
Iq-ai (LSE:IQAI)
Historical Stock Chart
From Sep 2024 to Oct 2024
Iq-ai (LSE:IQAI)
Historical Stock Chart
From Oct 2023 to Oct 2024